138 related articles for article (PubMed ID: 24077968)
21. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease.
Stahl K; Mylonakou MN; Skare Ø; Amiry-Moghaddam M; Torp R
Brain Res; 2011 Mar; 1378():105-18. PubMed ID: 21236244
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2.
Chao CC; Chiang CH; Ma YL; Lee EH
Neurobiol Aging; 2006 Jan; 27(1):105-18. PubMed ID: 16298246
[TBL] [Abstract][Full Text] [Related]
23. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
Mandel RJ; Snyder RO; Leff SE
Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205
[TBL] [Abstract][Full Text] [Related]
24. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
25. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of xyloketal B against MPP+-induced neurotoxicity in Caenorhabditis elegans and PC12 cells.
Lu XL; Yao XL; Liu Z; Zhang H; Li W; Li Z; Wang GL; Pang J; Lin Y; Xu Z; Chen L; Pei Z; Zeng J
Brain Res; 2010 May; 1332():110-9. PubMed ID: 20347725
[TBL] [Abstract][Full Text] [Related]
27. The protective effect of lactoferrin on ventral mesencephalon neurons against MPP + is not connected with its iron binding ability.
Wang J; Bi M; Liu H; Song N; Xie J
Sci Rep; 2015 Jun; 5():10729. PubMed ID: 26035688
[TBL] [Abstract][Full Text] [Related]
28. A non-peptidyl neurotrophic small molecule for midbrain dopaminergic neurons.
Lin LF; Rubin LL; Xu M
J Neurochem; 2004 Jun; 89(6):1387-95. PubMed ID: 15189341
[TBL] [Abstract][Full Text] [Related]
29. The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotine.
Guerreiro S; Florence C; Rousseau E; Hamadat S; Hirsch EC; Michel PP
Mol Pharmacol; 2015; 87(3):525-32. PubMed ID: 25552485
[TBL] [Abstract][Full Text] [Related]
30. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway.
Lotharius J; Falsig J; van Beek J; Payne S; Dringen R; Brundin P; Leist M
J Neurosci; 2005 Jul; 25(27):6329-42. PubMed ID: 16000623
[TBL] [Abstract][Full Text] [Related]
31. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.
Kress GJ; Reynolds IJ
Neurobiol Dis; 2005 Dec; 20(3):639-45. PubMed ID: 15996475
[TBL] [Abstract][Full Text] [Related]
32. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
[TBL] [Abstract][Full Text] [Related]
33. Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and neuroprotection.
Wiemerslage L; Lee D
Neurosci Lett; 2015 Jan; 584():342-6. PubMed ID: 25445363
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture.
Katsuki H; Okawara M; Shibata H; Kume T; Akaike A
J Neurochem; 2006 Jun; 97(5):1232-42. PubMed ID: 16638023
[TBL] [Abstract][Full Text] [Related]
35. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
36. Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease.
Chen T; Yang YF; Luo P; Liu W; Dai SH; Zheng XR; Fei Z; Jiang XF
Cell Signal; 2013 Dec; 25(12):2863-70. PubMed ID: 24036210
[TBL] [Abstract][Full Text] [Related]
37. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
38. Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism.
Krieglstein K; Unsicker K
J Neurosci Res; 1997 Apr; 48(1):18-30. PubMed ID: 9086178
[TBL] [Abstract][Full Text] [Related]
39. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.
Chung CY; Seo H; Sonntag KC; Brooks A; Lin L; Isacson O
Hum Mol Genet; 2005 Jul; 14(13):1709-25. PubMed ID: 15888489
[TBL] [Abstract][Full Text] [Related]
40. Dopamine Burden Triggers Neurodegeneration via Production and Release of TNF-α from Astrocytes in Minimal Hepatic Encephalopathy.
Ding S; Wang W; Wang X; Liang Y; Liu L; Ye Y; Yang J; Gao H; Zhuge Q
Mol Neurobiol; 2016 Oct; 53(8):5324-43. PubMed ID: 26433377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]